Wayland, MA, United States of America

Robert J Lutz

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 96(Granted Patents)


Company Filing History:


Years Active: 1997-2018

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovator Robert J. Lutz: Pioneering Treatments for Acute Myeloid Leukemia

Introduction

Robert J. Lutz is a distinguished inventor based in Wayland, MA, known for his significant contributions to the field of medical research. With a remarkable portfolio of 16 patents to his name, Lutz has made substantial advancements in the treatment of various diseases, particularly in oncology.

Latest Patents

Among his latest inventions, Lutz has developed the groundbreaking patent titled "Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same." This invention focuses on antibodies that selectively bind to CD33, a protein that is often overexpressed in acute myeloid leukemia (AML). The patent details various forms of these antibodies, including fragments and homologues, as well as humanized and resurfaced versions. Furthermore, it encompasses functional equivalents, immunoconjugates, and compositions that utilize these antibodies for diagnostic, research, and therapeutic applications. The invention also outlines the polynucleotides encoding these antibodies, vectors, and transformed host cells, showcasing a comprehensive approach to producing and applying these antibodies in clinical settings.

Career Highlights

Robert J. Lutz has been a pivotal figure in the biotech industry, primarily working with organizations such as Immunogen, Inc. and Apoptosis Technology, Inc. His work at these companies has further established him as an authority in his field, allowing him to explore innovative avenues in antibody development and therapeutic applications.

Collaborations

Throughout his career, Lutz has collaborated with esteemed colleagues, including Mary G. Hoffee and Daniel J. Tavares. These partnerships have fostered a collaborative environment that promotes innovation and accelerated advancements in medical research.

Conclusion

In conclusion, Robert J. Lutz is an influential inventor whose work has the potential to transform the landscape of acute myeloid leukemia treatment. His dedication to developing effective therapeutic solutions through innovative antibody research exemplifies the impact that inventors have on advancing medical science and improving patient outcomes. The future of cancer treatment continues to shine brightly with the contributions of innovators like Lutz.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…